Virosome-mediated delivery of protein antigens to dendritic cells

Vaccine

Volumn 20, Issue 17-18, 2002, Pages 2287-2295

  Bungener, Laura ^a   Serre, Karine ^b   Bijl, Liesbeth ^a   Leserman, Lee ^b   Wilschut, Jan ^a   Daemen, Toos ^a   Machy, Patrick ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

Antigen presentation; Dendritic cells; Virosomes

Indexed keywords

ANTIGEN; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; VIROSOME; VIRUS FUSION PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; ENCAPSULATION; HELPER CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; BIOLOGICAL MARKERS; CYTOPLASM; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERCELLULAR ADHESION MOLECULE-1; LIPOSOMES; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; OVALBUMIN; RECEPTORS, IGG; TUMOR CELLS, CULTURED; UP-REGULATION; VIROSOMES;

EID: 0037157276     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00103-2     Document Type: Article

References (36)

1. Immunobiology of dendritic cells
2. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
3. Dendritic cells require T cells for functional maturation in vivo
4. Introduction of soluble protein into the class I pathway of antigen processing and presentation
5. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: Immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide
6. Development of non-live vectors and procedures (liposomes, pseudo-viral particles, toxin, beads, adjuvants ...) as tools for cancer vaccines
7. Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes)
8. Functional reconstitution of influenza virus envelopes
9. Infectious entry pathway of influenza virus in a canine kidney cell line
10. Entry and uncoating of enveloped viruses
11. The influenza virus hemagglutinin: Membrane fusion activity in intact virions and reconstituted virosomes
12. Mechanisms of membrane fusion
13. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin
14. Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted influenza virus envelopes (virosomes)
15. Delivery of foreign substances to cells mediated by fusion-active reconstituted influenza virus envelopes (virosomes)
16. Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles
17. Lipid bilayers and biomembranes
18. Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells
19. Class I-restricted presentation of exogenous antigen acquired by Fcγ receptor-mediated endocytosis is regulated in dendritic cells
20. T cell receptor antagonist peptides induce positive selection
21. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures
22. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation
23. A rapid and sensitive sub-micro phosphorous determination
24. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes
25. The JAM test A simple assay for DNA fragmentation and cell death
26. Fusion of reconstituted influenza virus envelopes with liposomes mediated by streptavidin/biotin interactions
27. Evaluation of viral membrane fusion assays. Comparison of the octadecylrhodamine dequenching assay with the pyrene excimer assay
28. Activation of murine lymphocytes by lipopolysaccharide incorporated in fusogenic, reconstituted influenza virus envelopes (virosomes)
29. Importance of CD4+ T helper cell responses in tumor immunity
30. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells
31. Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway
32. Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy
33. Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes
34. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses
35. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation
36. Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes